dxsgenotyping
Precision in Genotyping and Molecular Diagnostics
At [dxsgenotyping], we harness the power of genomics, molecular diagnostics, and innovative genetic testing technologies to transform medical research and clinical decision-making. Our laboratory combines cutting-edge instrumentation, high-throughput sequencing, and bioinformatics analysis to deliver precise, actionable insights for researchers, clinicians, and biotech innovators worldwide.
Who We Are
We are a world-class genotyping and molecular diagnostics facility located in the vibrant research district of Manchester. Our custom-built, high-tech laboratories adjoin the University of Manchester’s Biological Sciences and Medical Schools, giving us instant access to cutting-edge research and clinical innovation.
Advanced Genotyping for Modern Research
Understanding genetic variation is at the heart of modern biomedical research. Our comprehensive genotyping services allow scientists to:
- Identify single nucleotide polymorphisms (SNPs) and structural variants Read more
- Investigate gene-environment interactions Read more
- Support population genetics studies and disease association research
Using next-generation sequencing (NGS) and microarray platforms, we provide high-resolution genetic data with unmatched accuracy, enabling discoveries that accelerate personalized medicine and therapeutic development.
Molecular Diagnostics
Accuracy You Can Trust
Our molecular diagnostic solutions combine sensitivity, specificity, and speed to detect genetic disorders, infectious agents, and biomarkers critical to patient care and research projects. With real-time PCR, digital PCR, and sequencing technologies, we ensure that every sample yields reliable, reproducible results.
Applications include:
Oncology research:
Identifying tumor mutations and targeted therapy markers.
Infectious disease detection:
rapid molecular diagnostics for viruses, bacteria, and other pathogens.
Pharmacogenomics:
Tailoring treatments based on individual genetic profiles.
Reproductive health:
Detecting inherited disorders and guiding fertility interventions
Our Expertise
High-throughput Genotyping
We analyze thousands to millions of genetic markers including SNPs, CNVs, and structural variants using the latest array technologies and next-generation sequencing (NGS) methods. This allows us to uncover genetic insights quickly and cost-effectively, supporting everything from basic research to clinical applications.
Molecular Diagnostic Testing
We develop and run molecular assays to detect DNA/RNA targets for inherited disorders, infectious diseases, and oncology, delivering precise, actionable clinical information for healthcare providers and research teams.
Read more
Genetic Testing for Research and Healthcare
From pharmacogenomics, which tailors drug therapy to a patient’s genome, to non-invasive prenatal testing (NIPT) and liquid biopsy genotyping, our services empower scientific discovery and personalized medicine. Read more
Why Choose Us?
Strategic Location: Adjacent to Manchester Royal Infirmary and the Wellcome Trust Millennium Clinical Research Facility, we bridge the gap between bench and bedside.
Rapid Innovation: We adopt emerging technologies, including digital PCR and AI-enhanced nucleic acid testing, to improve sensitivity, accuracy, and turnaround times.
Comprehensive Service: Whether you need SNP genotyping arrays, custom assays, or full molecular pathology workflows, our team delivers robust, validated results.
Service | Applications |
SNP and genome-wide genotyping | GWAS, trait mapping, population studies |
Targeted mutation panels and NGS diagnostics | Oncology, inherited diseases, pathogen detection |
Non-invasive and liquid biopsy genotyping | Prenatal screening, cancer recurrence monitoring |
Pharmacogenomic profiling | Personalized drug dosing and safety |
Advanced Technologies and Laboratory Capabilities
Our lab combines state-of-the-art equipment with a team of molecular biologists, geneticists, and bioinformaticians to deliver services at the forefront of biomedical science.
Our capabilities include:
FAQ
Q1: What is genotyping?
A1: Genotyping is a technique that identifies genetic variations (SNPs, mutations) in DNA. It is widely used in genomic research, pharmacogenomics, and personalized medicine, providing insights for both scientific discovery and clinical decision-making. Genotyping helps researchers and clinicians understand disease susceptibility, drug response, and inherited traits.
Q2: What are molecular diagnostics?
A2: Molecular diagnostics are methods for detecting DNA or RNA targets to identify pathogens or genetic mutations. Techniques include PCR, sequencing, and isothermal amplification. Molecular diagnostics are critical for infectious disease testing, oncology, and genetic disorder screening, providing fast, accurate, and reliable results for research and clinical applications.
Q3: Who can use DxS services?
A3: Our services are available to universities, clinical research centers, pharmaceutical R&D departments, biotechnology companies, and biomedical institutes, supporting scientific innovation, translational research, and healthcare advancements.
Q4: What are the benefits of genotyping in medical research?
A4: Genotyping provides high-resolution insights into genetic variations, helping researchers identify disease markers, drug response profiles, and hereditary risk factors. It enables precision medicine, population genetics studies, and biomarker discovery, improving research outcomes and clinical interventions.
Q5: How does genotyping differ from genetic sequencing?
A5: Genotyping focuses on identifying specific genetic variations such as SNPs or targeted mutations, while genetic sequencing determines the entire DNA or RNA sequence. Both are complementary in genomic research, molecular diagnostics, and personalized medicine.
Q6: Can molecular diagnostics detect emerging pathogens?
A6: Yes, molecular diagnostics can rapidly detect emerging pathogens, viral mutations, and antibiotic-resistant strains using advanced PCR, NGS, and isothermal amplification methods. This capability is essential for public health monitoring and outbreak management.
Q7: How reliable are DxS genotyping and molecular diagnostic services?
A7: DxS maintains international quality standards, uses state-of-the-art equipment, and ensures accuracy, reproducibility, and data security. Every workflow is validated, making our results trusted by researchers, clinicians, and pharmaceutical partners worldwide.
Q8: Can genotyping be used in reproductive medicine?
A8: Absolutely. Genotyping is widely applied in fertility clinics and reproductive research for preimplantation genetic testing, embryo screening, and carrier screening, helping reduce the risk of hereditary disorders and improve fertility outcomes.
Q9: What technologies does DxS use for molecular diagnostics?
A9: DxS uses real-time PCR (qPCR), digital PCR (dPCR), isothermal amplification (LAMP), targeted sequencing, and next-generation sequencing (NGS). These technologies provide high sensitivity and specificity, suitable for clinical diagnostics, research studies, and pharmacogenomics applications.
Q10: How can I get started with DxS services?
A10: To start, contact DxS via our website or customer service team. We offer consultation, project design, and tailored genetic testing solutions for research, clinical, and industrial applications, helping you achieve reliable and actionable results.